A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients. - de Jonge AV; van Werkhoven E; Dinmohamed AG; Nijland M; Zwinderman AH; Bossuyt PM; Veldhuis MS; Rutten EGGM; Mous R; Vermaat JSP; Sandberg Y; de Jongh E; et al. (Blood cancer journal, 2023)